FIELD: medicine.
SUBSTANCE: invention relates to composition with potent matrix metalloproteinase inhibition activity. Claimed composition contains catechin, ascorbic acid, prolin and lysin and is useful in treatment of inflammation, infective, cardiovascular degenerative, neurological and autoimmune diseases.
EFFECT: new composition for inhibition of matrix metalloproteinases.
26 cl, 7 ex, 9 dwg
Authors
Dates
2006-09-27—Published
2002-01-31—Filed